lung cancer
Conditions
Interventions
Group T:Oliceridine analgesia
Group C:Sufentanil analgesia
Sponsors
Quzhou People Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patient informed consent; 2.ASA I-II; 3.Age 30-65 years old; 4.Body mass index (BMI) 18.5-30 kg/m^2; 5.No serious heart, lung, liver, kidney and other diseases; 6.The coagulation function test was normal; 7.Thoracoscopic resection of lung tumor was performed in all cases;
Exclusion criteria
Exclusion criteria: 1.The patient refused to participate in the trial; 2.Brain disease, abnormal judgment; 3.History of related drug allergies; 4.Participated in other clinical investigators within 3 months; 5.Pregnant or lactating women;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MAP;HR;BIS;nausea or volmting;pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| usage of propofol;usage of remifentanil;extubation time; | — |
Countries
China
Contacts
Public ContactXiangyu Fang
Quzhou People Hospital
Outcome results
None listed